3 questions: Leveraging insights to enable clinical outcomes
Thomas Heldt, associate director of IMES, describes how he collaborates closely with MIT colleagues and others at Boston-area hospitals.
Thomas Heldt, associate director of IMES, describes how he collaborates closely with MIT colleagues and others at Boston-area hospitals.
The late-in-life health care option reduces patient costs, even as for-profit organizations expand in the sector.
Professors Matthew Vander Heiden and Fan Wang, along with five MIT alumni, are honored for their outstanding professional achievement and commitment to service.
The noninvasive screening procedure can reduce pregnancy risks and lower costs at the same time, but only when targeted effectively.
Alumni-founded Ambience Healthcare automates routine tasks for clinicians before, during, and after patient visits.
Inspired by traditional medicine, 17-year-old Tomás Orellana is on a mission to identify plants that can help treat students’ health issues.
New statistical models based on physiological data from more than 100 surgeries provide objective, accurate measures of the body’s subconscious perception of pain.
Researchers argue that in health care settings, “responsible use” labels could ensure AI systems are deployed appropriately.
Hanna Adeyema and Carolina Haass-Koffler discuss the substance use disorder crisis and the future of innovation in the field.
“ScribblePrompt” is an interactive AI framework that can efficiently highlight anatomical structures across different medical scans, assisting medical workers to delineate regions of interest and abnormalities.
The new device, which can be implanted under the skin, rapidly releases naloxone when an overdose is detected.
A mathematical method, validated with experimental data, provides a fast, reliable, and minimally invasive way of determining how to treat critical blood pressure changes during surgery or intensive care.
The company that brought you no-stick toothpaste is moving into the medical space, with a lubricant for ostomy pouches and other products that could improve millions of lives.
The model could help clinicians assess breast cancer stage and ultimately help in reducing overtreatment.
This tiny, biocompatible sensor may overcome one of the biggest hurdles that prevent the devices from being completely implanted.